APP下载

灯盏生脉胶囊对血管性认知功能障碍患者的疗效及部分机制

2019-09-10喻露阿依努尔杜泽慧

世界中医药 2019年8期
关键词:中医证候积分氧化应激

喻露 阿依努尔 杜泽慧

摘要 目的:评估灯盏生脉胶囊对血管性认知功能障碍(VCI)的疗效,探讨其实现作用的可能机制。方法:选取2015年12月至2018年7月新疆军区总医院首诊为VCI的患者130例作为研究对象,按照随机数表法将其分为对照组和观察组,每组65例。对照组患者接受临床VCI患者常规西医治疗,观察组患者在对照组基础上加入灯盏生脉胶囊,持续治疗3个月后评估疗效。比较2组患者认知功能量表评分及中医证候积分、血管内皮功能指标[内皮素-1(ET-1)、一氧化氮(NO)]及氧化应激指标[超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)、丙二醛(MDA)]的水平,药物不良反应发生情况的差异。结果:治疗后,观察组的MoCA评分值高于对照组,血管性痴呆的中医辨证量表(SDSVD)评分值低于对照组;智能衰退、反应迟钝、头晕耳鸣、纳呆等中医证候积分值低于对照组;血清中ET-1的水平低于对照组,NO的水平高于对照组;血清中SOD、GSH-Px的水平高于对照组,MDA的水平低于对照组,差异有统计学意义(P<0.05)。2组服药期间皮疹、腹泻便秘的发生率差异无统计学意义(P>0.05)。结论:灯盏生脉胶囊可有效改善VCI患者的認知功能且有良好的用药安全性,其作用机制可能与调节血管内皮功能、抗氧化应激等相关。

关键词 血管性认知功能障碍;灯盏生脉胶囊;中医证候积分;血管内皮功能;氧化应激

Abstract Objective:To evaluate the effect of Dengzhan Shengmai Capsule on vascular cognitive impairment(VCI)and explore its possible mechanism.Methods:A total of 130 cases of VCI patients first diagnosed in our hospital during December 2015 to July 2018 were divided into control group and Dengzhan Shengmai Capsule group each with 65 cases by random number table method.Patients in control group were treated with routine western medicine treatment,those in the Dengzhan Shengmai Capsule group added Dengzhan Shengmai Capsule on the basis of control group.The curative effect was evaluated after 3 months of continuous treatment.The differences of cognitive function scale score,TCM syndrome score,vascular endothelial function indexes[Endothelin-1(ET-1)and nitric oxide(NO)],oxidative stress indexes[Superoxide dismutase(SOD),glutathione peroxidase(GSH-Px),malondialdehyde(MDA)] and adverse drug reactions between two groups were compared.Result:After treatment,score of MoCA in Dengzhan Shengmai Capsule group was higher than those in control group,while score of SDSVD in SDSVD group was lower than those in control group; scores of TCM syndromes such as mental decline,slow reaction,dizziness,tinnitus and dementia were lower than those in control group; serum content of ET-1 was lower than that in control group,NO was higher than that in control group; serum contents of SOD and GSH-Px in serum were higher than those in control group(P<0.05).There were no significant difference in the incidences of skin rash,diarrhea and constipation between two groups(P>0.05).Conclusion:Dengzhan Shengmai Capsules can effectively improve the cognitive function of VCI patients and has good drug safety.Its mechanism may be related to the regulation of vascular endothelial function and antioxidant stress.

Key Words Vascular cognitive impairment; Dengzhan Shengmai Capsules; Integral of TCM Syndrome; Vascular endothelial function; Oxidative stress

中图分类号:R289.5文献标识码:Adoi:10.3969/j.issn.1673-7202.2019.08.039

血管性认知功能障碍(Vascular Cognitive Impairment,VCI)是由高血压、糖尿病等脑血管病危险因素及脑血管病引起的,从早期认知障碍到痴呆的一类综合疾患[1-2]。……

登录APP查看全文

猜你喜欢

中医证候积分氧化应激
基于炎症-氧化应激角度探讨中药对新型冠状病毒肺炎的干预作用
无比山药丸加减治疗气阴两虚型肾性血尿的疗效及机制研究
对暑湿型普通感冒患者给予自拟退热利湿汤治疗的效果探究
补肝除痹汤治疗颈椎病100例临床研究
胃痛消方治疗老年慢性浅表性胃炎的临床观察
中医内科治疗特发性间质性肺炎患者的效果
补脑熄风止痉汤治疗帕金森病的临床疗效观察
氧化应激与糖尿病视网膜病变
尿酸对人肝细胞功能及氧化应激的影响
乙肝病毒S蛋白对人精子氧化应激的影响